Effects of drugs and anticytokine antibodies on expression of ATP2A2 and ATP2C1 in cultured normal human keratinocytes

British Journal of Dermatology

Volumn 152, Issue 5, 2005, Pages 920-924

  Mayuzumi, N ^a   Ikeda, S ^a   Kawada, H ^a   Ogawa, H ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium; Cytokines; Darier's disease; Gene expression; Hailey Hailey disease; Reverse transcriptase polymerase chain reaction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); COLECALCIFEROL; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; MESSENGER RNA; PREDNISOLONE; RETINOIC ACID; RETINOID; TACROLIMUS;

ARTICLE; ATP2A2 GENE; ATP2C1 GENE; AUTOSOMAL DOMINANT DISORDER; CELL CULTURE; CONTROLLED STUDY; DARIER DISEASE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE MUTATION; GENE REPRESSION; GOLGI COMPLEX; HAILEY HAILEY DISEASE; HOMEOSTASIS; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; RADIATION EXPOSURE; SARCOPLASMIC RETICULUM; SKIN INFLAMMATION; ULTRAVIOLET B RADIATION;

ANTIBODIES; CALCIUM-TRANSPORTING ATPASES; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; INTERLEUKIN-6; INTERLEUKIN-8; KERATINOCYTES; KERATOSIS FOLLICULARIS; PEMPHIGUS, BENIGN FAMILIAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRETINOIN; ULTRAVIOLET RAYS;

EID: 18944376567     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06394.x     Document Type: Article

References (31)

1. 2+ pump, cause Darier disease. Nat Genet 1999; 21:271-7.
2. Hu Z, Bonifas JM, Beech J et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet 2000; 24:61-5.
3. Ikeda S, Shigihara T, Mayuzumi N et al. Mutations of ATP2C1 in Japanese patients with Hailey-Hailey disease: intrafamilial and interfamilial phenotype variations and lack of correlation with mutation patterns. J Invest Dermatol 2001; 117:1654-6.
4. Ikeda S, Mayuzumi N, Shigihara T et al. Mutations in ATP2A2 in patients with Darier's disease. J Invest Dermatol 2003; 121:475-7.
5. Burge S. Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol 1992; 126:275-82.
6. Mayuzumi N, Ikeda S, Kawada H et al. Effects of various stimuli on the expression of ATP2A2 and ATP2C1. Br J Dermatol, in press.
7. Ansel J, Perry P, Brown J et al. Cytokine modulation of keratinocytes cytokines. J Invest Dermatol 1990; 94:101S-7S.
8. Kondo S, Kono T, Sander DN, Mckenzie RC. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol 1993; 101:690-4.
9. Köck A, Schwarz T, Kirnbauer R et al. Human keratinocytes are a source of tumor necrosis factor: evidence for synthesis and release upon stimulation and endotoxin or ultraviolet light. J Exp Med 1990; 172:1609-14.
10. Kirnbauer R, Kock A, Neuner P et al. Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol 1991; 96:484-9.
11. Ikeda S, Suga Y, Ogawa H. Successful management of Hailey-Hailey disease with potent topical steroid ointment. J Dermatol Sci 1993; 5:205-11.
12. Berth-Jones J, Smith SG, Graham-Brown RA. Benign familial chronic pemphigus (Hailey-Hailey disease) responds to cyclosporin. Clin Exp Dermatol 1995; 20:70-2.
13. Rabeni EJ, Cunningham NM. Effective treatment of Hailey-Hailey disease with topical tacrolimus. J Am Acad Dermatol 2002; 47:797-8.
14. Hunt MJ, Salisbury EL, Painter DM, Lee S. Vesiculobullous Hailey-Hailey disease: successful treatment with oral retinoids. Australas J Dermatol 1996; 37:196-8.
15. Cooper SM, Burge SM. Darier's disease: epidemiology, pathophysiology, and management. Am J Clin Dermatol 2003; 4:97-105.
16. Müschen A, Mirmohammadsadegh A, Jarzebska-Deussen B et al. Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes. Inflamm Res 1999; 48:539-43.
17. Corsini E, Viviani B, Marinovich M, Galli CL. Cyclosporin A exacerbates skin irritation induced by tributyltin by increasing nuclear factor κ B activation. J Invest Dermatol 2001; 117:1617-34.
18. Taniguchi S, Kono T, Ishii M et al. Effects of cyclosporin and ultraviolet radiation on growth and ornithine decarboxylase activity in cultured human epidermal keratinocytes. Br J Dermatol 1995; 132:703-9.
19. Fukuoka M, Sakurai K, Ohta T et al. Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes. Skin Pharmacol Appl Physiol 2001; 14:226-33.
20. Ratnam AV, Bikle DD, Su MJ, Pillai S. Squamous carcinoma cell lines fail to respond to 1,25-dihydroxyvitamin D despite normal levels of the vitamin D receptor. J Invest Dermatol 1996; 106:522-5.
21. Rendl M, Ban J, Mrass P et al. Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner. J Invest Dermatol 2002; 119:1150-5.
22. Braungart E, Migdolen V, Degitz K. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes. J Invest Dermatol 2001; 116:778-84.
23. Fogh K, Solvsten H, Johnke H, Kragballe K. All-trans retinoic acid inhibits binding of 1,25-dihydroxy-vitamin D3 to the vitamin D receptor in cultured human keratinocytes. Exp Dermatol 1996; 5:24-7.
24. Chung JH, Youn SH, Koh WS et al. Ultraviolet B irradiation-enhanced interleukin (IL)-6 production and mRNA expression are mediated by IL-1 alpha in cultured human keratinocytes. J Invest Dermatol 1996; 106:715-20.
25. Nakano H, Kimura J, Kumano T et al. Decrease in class Pi gutathione transferase mRNA levels by ultraviolet irradiation of cultured rat keratinocytes. Jpn J Cancer Res 1997; 88:1063-9.
26. Longuet-Perret I, Schmitt D, Viac J. Tumor necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br J Dermatol 1998; 138:221-4.
27. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996; 20:1002-13.
28. Kohase M, Henriksen-Destefano D, Sehgal PB, Vilcek J. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin 1 and epidermal growth factor in human fibroblasts. J Cell Physiol 1987; 132:271-8.
29. Nishio H, Matsui K, Tsuji H et al. Immunolocalization of calcineurin and FKBP12, the FK506-binding protein, in Hassall's corpuscles of human thymus and epidermis. Histochem Cell Biol 2000; 114:9-14.
30. Karashima T, Hachisuka H, Sasai Y. FK506 and cydosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle. J Dermatol Sci 1996; 12:246-54.
31. Moutabarrik A, Nakanishi I, Takahara S et al. Effect of immunosuppressive agents FK506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes. Transpl Int 1994; 7 (Suppl. 1):S552-5.